Anesthesia Feasibility Study With the CONCERT-CL® Station
NCT ID: NCT02889718
Last Updated: 2019-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
60 participants
INTERVENTIONAL
2015-02-16
2016-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is a prospective, open, non-controlled, non-randomized, monocentric study. The main objective is to study the potential contribution of the system in the conduct of anaesthesia, as decision support, for the administration of the hypnotic agent.
Secondary objectives will include hemodynamic stability, and the average concentrations of opioid and hypnotic anesthetic agents evaluated from the pharmacokinetic model.
The study will involve surgical patients scheduled for surgery under general anesthesia for more than 1 (one) hour.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interest of the Study of Electroencephalogram and Peripheral Vegetative Markers for the Evaluation of Nociception Under General Anesthesia.
NCT03994887
NoL Monitor Performances of Nociceptive and Non-nociceptive Stimuli Discrimination During Robotic Surgery
NCT04566536
Hypnosis and Closed-Loop Anesthesia System
NCT01648725
Manual Administration of Propofol-remifentanil Versus Dual Closed-loop Using Bispectral Index as the Control Variable
NCT00392158
Comparison of the Bispectral Index and the Entropy of the Electroencephalogram During Total Intravenous Anesthesia
NCT00391963
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
anaesthesia with CONCERT-CL® station
During the surgery, 3 drugs usually used for anaesthesia will be administered by the CONCERT-CL® station
CONCERT-CL® station
During cancer surgery (surgery \> 1 hour), CONCERT-CL® station will be used in accordance with its CE marking to administer anesthetic agents:
* Port B = open loop: Analgesic
* Port A = closed loop: Hypnotic
* Port C = closed loop: Curare
Surgery
Regardless of the type of surgery the patient receives for his cancer, this surgery must be greater than 1 hour.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CONCERT-CL® station
During cancer surgery (surgery \> 1 hour), CONCERT-CL® station will be used in accordance with its CE marking to administer anesthetic agents:
* Port B = open loop: Analgesic
* Port A = closed loop: Hypnotic
* Port C = closed loop: Curare
Surgery
Regardless of the type of surgery the patient receives for his cancer, this surgery must be greater than 1 hour.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Surgery of any type programmed for longer than 1 hour
* Anesthesia combining three agents: hypnotic, morphine, curare
Exclusion Criteria
* pregnant and lactating women
* Known or suspected hypersensitivity to propofol,
* known or suspected hypersensitivity to remifentanil and other fentanyl derivatives,
* known or suspected hypersensitivity to rocuronium and atracurium, preventing the use of the two products.
* peanut allergy, soy, Egg
* neurological disease history with known modification of the electroencephalogram
* severe eye disease, ocular implant, standing diabetes with diabetic retinopathy
* gravis
* pacemakers patient
* surgery whose position is not suitable for a monitoring on the ulnar nave
* general anesthesia associated with regional anesthesia
* Simultaneous use of shortwave therapy or microwave
* Simultaneous use of high frequency surgical apparatus
* 15 patients under supervision or unable to consent
* patient undergoing psychiatric care
* patient in a health or social institution
* emergency
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Cancerologie de l'Ouest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MAVOUNGOU Philippe, MD
Role: PRINCIPAL_INVESTIGATOR
Institut de Cancérologie de l'Ouest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ICO
Saint-Herblain, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ICO-N-2014-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.